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Abstract
Background: Transplantation is often the best, if not the only treatment for end-stage organ failure; however, the
quality metrics for determining whether a transplant program is delivering safe, high quality care remains unknown.
The purpose of this study is to identify and describe quality indicators or metrics in patients who have received a
solid organ transplant.
Methods/design: We will conduct a systematic scoping review to evaluate and describe quality indicators or
metrics in patients who have received a solid organ transplant. We will search MEDLINE, Embase, and the Cochrane
Central Register for Controlled Trials. Two reviewers will conduct all screening and data extraction independently.
The articles will be categorized according to the six domains of quality, and the metrics will be appraised using
criteria for a good quality measure.
Discussion: The results of this review will guide the development, selection, and validation of appropriate quality
metrics necessary to drive quality improvement in transplantation.
Systematic review registration: PROSPERO CRD42016035353.
Keywords: Solid organ transplantation, Quality, Health indicators
Background
Transplantation is the only treatment for some types of
end-stage organ failure (e.g., liver) while it is the treat-
ment of choice for others (e.g., kidney). In the case of
kidney failure, transplantation is preferred since it im-
proves quality of life, prolongs survival, and is less costly
compared to dialysis [1–3]. From the perspective of the
patient and the healthcare system, however, major prob-
lems remain in transplantation including lack of appro-
priate access; premature transplant failure and death;
and reduced quality of life due to various complications.
The best approach for determining whether a trans-
plant program is delivering high-quality, safe care re-
mains unknown [4–6]. The USA has instituted
mandatory reporting of survival data from all transplant
hospitals [4]; however, this metric on its own may not
adequately capture all aspects of transplant program
quality as “poor” performance may lead to reduced ac-
cess to transplantation services [4, 7, 8]. Healthcare
quality encompasses important dimensions beyond ef-
fectiveness outcomes (e.g., graft survival), such as access
to treatment, patient-centeredness, safety, and equity [9].
In transplantation, these aspects of quality are less well
known. The purpose of this study is to systematically
identify and review all quality metrics/indicators that
have been used in the practice of solid organ
transplantation.
Research objectives
The aim of this study is to systematically review the lit-
erature in order to identify and describe the indicators/
metrics that are used to measure the quality of care pro-
vided to solid organ transplant recipients. Our objectives
are the following: first, to describe which quality metrics
are being reported and how they are being used in solid
organ transplantation; second, to categorize these
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metrics within the domains of quality [9]; and third, to




A comprehensive electronic literature search will be
conducted in MEDLINE, Embase, and the Cochrane
Central Register for Controlled Trials (CENTRAL) from
inception to April 2016. The references of the included
studies and existing reviews will be scanned for add-
itional studies that were not identified by the search.
The search strategy will be developed with the assistance
of a medical librarian experienced in systematic reviews.
A structured search strategy will be based on controlled
vocabulary and relevant key terms, and will be broad to
prioritize sensitivity (Additional file 1). Key search terms
will include “quality”, “quality indicator”, “quality im-
provement” and ”quality of health care”. The language of
publication will be restricted to the English language.
This review has been registered with PROSPERO
(CRD42016035353).
Study screening and inclusion
Literature search results will be uploaded to EndNote
X7 software, which will be used to find and remove du-
plicates. References will be sorted alphabetically by title
and exported to Microsoft Word for screening. Two in-
dependent reviewers will screen the titles and abstracts
(stage 1) against the inclusion criteria. Additional dupli-
cates that may be missed by the referencing software will
be identified during the screening process. For all titles
and abstracts that appear potentially eligible, we will ob-
tain full-text reports. If no abstract is available for a
given citation, then the full-text will be obtained unless
the article can be confidently excluded by its title alone.
Two independent reviewers will screen all full-text re-
ports to determine whether they meet the inclusion cri-
teria (stage 2). Prior to the formal screening process, the
two reviewers will participate in a short pilot exercise to
identify and address any inconsistencies in the applica-
tion of the screening criteria. A third reviewer will rec-
oncile any disagreements between the two reviewers
regarding an article’s inclusion status. The study selec-
tion process will be summarized using a PRISMA flow
diagram [11].
Study eligibility criteria
Studies will be selected according to predefined criteria.
Peer reviewed, published articles will be included if they
evaluate, measure, or review quality metrics/indicators
in solid organ transplantation. Quality metrics are de-
fined as “any objective measure that has been developed
to support self-assessment and quality improvement at
the provider, hospital and/or health care system” [12].
To be included, the metrics/indicators must be capable
of some degree of quantification [13] and related to the
quality of care that is provided to the transplant recipi-
ents by a transplant program. All metrics (e.g., structure,
process, and outcomes) will be considered [6]. Metrics
will be excluded for the following reasons: (i) they are
not capable of some degree of quantification, (ii) the
metric is dependent on non-modifiable factors, (iii) the
metric is related to the organ donor or the organ pro-
curement process, and (iv) the metric is used as a pre-
dictive tool, rather than an assessment of quality. We
will include studies examining humans of all ages who
have undergone a solid organ transplant (kidney, heart,
liver, lung, pancreas, small bowel, and combinations of
these organs). We will exclude studies involving bone
marrow and cell transplants. There will be no restric-
tions on the design of the study, the type of setting, or
the length of follow-up for outcomes.
Data extraction
Data will be extracted from each eligible study by two
independent reviewers using a pre-designed form in
Microsoft Excel. The form will be pilot tested to ensure
it captures all the relevant information. Any discrepan-
cies that cannot be resolved by discussion will be adjudi-
cated by a third reviewer.
Information pertaining to study identification (author,
year of publication, number and location of centers,
funding, and journal), study design (type of study, sam-
ple size, eligibility criteria, and length of follow-up), ag-
gregate patient characteristics (age, gender, organ(s)
studied, length of time since transplant, and comorbidi-
ties), and relevant quality metrics (name of metric(s),
type of metric, measurement time points, the compara-
tor outcome, main findings, and limitations of the
metric) will be extracted.
Data synthesis
We will use the PRISMA statement to guide the reporting
of our findings. A completed copy of the PRISMA-P check-
list is included as an additional file (Additional file 2). For
all included studies, we will provide a detailed description
of the quality metrics in both tables and text. The data will
be organized based on organ type and population [adult
(≥18 years) vs. pediatric (<18 years)]. The metrics will be
categorized into the six domains of quality: access, equit-
able, patient-centered, efficiency, safety, and effectiveness
(described in Table 1) [9, 14]. The quality metrics will be
appraised using Janakiraman and Eker’s [10] criteria for a
good measure: (i) easy to define and observe; (ii) important
to patients and healthcare providers; (iii) amenable to
change; and (iv) obtainable from existing or easily collected
data. This appraisal will be presented as a table (Additional
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file 3), with each of the criteria receiving a score of “yes”,
“no”, or “unclear”. This tool will not be used to calculate a
score for each quality metric, but rather to present whether
each metric meets some or all of the criteria for a good
measure. It is expected that the data will be very heteroge-
neous, due to variations in the organs studied, the popula-
tions, the quality metrics, and the comparator measures/
outcomes; therefore, no statistical analysis is planned.
Metrics meeting all of the criteria for a good measure will
be identified, and a narrative synthesis will be used to com-
pare and describe how the metrics are being used within
each quality domain.
Discussion
The aim of this systematic scoping review is to evaluate
and describe quality metrics that are used in solid organ
transplantation. The rigorous and systematic nature of
our review will ensure that it captures all relevant infor-
mation on quality metrics in organ transplantation. Due
to the multiple domains of quality, we have purposely
created a relatively broad search strategy and study in-
clusion criteria in order to capture the most comprehen-
sive look at quality metrics that are being used or have
been proposed in solid organ transplantation. Reliable
and valid quality metrics are necessary to establish base-
line performance, to determine areas that need improve-
ment, and to determine if practice changes have led to
progress. The results of this study will identify innova-
tive transplant quality indicators, which will help to
guide the selection of core quality metrics which are
suitable for further study, and can be used in subsequent
transplant quality improvement initiatives that will ac-
tively measure and promote improvements in health
outcomes.
Additional files
Additional file 1: Search strategies. The data provided shows the
comprehensive search strategy for each database. (DOCX 15.5 kb)
Additional file 2: PRISMA-P checklist. The data provided shows a
completed copy of the PRISMA-P checklist to guide readers in assessing
the quality of the current protocol. (DOCX 39.5 kb)
Additional file 3: The appraisal of candidate measures using the criteria
for a good measure. The data provided demonstrates the tool that will
be used to determine if a quality metric meets the criteria for a good
measure. (DOCX 18.6 kb)
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